Dr. Reddy's Share Price Gains Following Q4 Profit Beat
Dr. Reddy's Laboratories Ltd.'s shares rose over 2% after reporting fourth-quarter results for fiscal 2025. The pharmaceutical giant's consolidated net profit increased 22%, surpassing analysts' expectations.
The company announced a net profit of Rs 1,593 crore for the quarter ending March 2025, exceeding the Rs 1,459 crore forecast by analysts tracked by Bloomberg. This strong performance was reflected in the revenue figures, which rose by 20% to Rs 8,528 crore, compared to the Bloomberg estimate of Rs 8,359.7 crore.
Dr. Reddy's Ebitda climbed 13.3% to Rs 2,074.7 crore, although it fell short of the estimated Rs 2,268.6 crore. The company's margin stood at 24.3%, slightly below the Bloomberg estimate of 27.1%.
Dr. Reddy's Laboratories was founded in 1984 and the company specialises in the production of generic medications, active pharmaceutical ingredients, and biosimilars. The company operates globally, with a strong presence in markets such as the United States, Europe, and India.
Dr. Reddy's Share Price Today
The scrip rose as much as 2.51% to Rs 1,184 apiece. It pared gains to trade 0.35% higher at Rs 1,159.90 apiece, as of 09:49 a.m. This compares to a 2.51% advance in the NSE Nifty 50.
It has fallen 1.85% in the last 12 months. Total traded volume so far in the day stood at 4.6 times its 30-day average. The relative strength index was at 49.
Out of 38 analysts tracking the company, 15 maintain a 'buy' rating, 11 recommend a 'hold' and 12 suggest 'sell', according to Bloomberg data. The average 12-month analysts' consensus price target implies an upside of 9.4%.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
